These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38737525)

  • 1. Controlled Lipid Self-Assembly for Scalable Manufacturing of Next-Generation Immune Stimulating Complexes.
    Pires IS; Ni K; Melo MB; Li N; Ben-Akiva E; Maiorino L; Dye J; Rodrigues KA; Yun D; Kim B; Hosn RR; Hammond PT; Irvine DJ
    Chem Eng J; 2023 May; 464():. PubMed ID: 38737525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity.
    Silva M; Kato Y; Melo MB; Phung I; Freeman BL; Li Z; Roh K; Van Wijnbergen JW; Watkins H; Enemuo CA; Hartwell BL; Chang JYH; Xiao S; Rodrigues KA; Cirelli KM; Li N; Haupt S; Aung A; Cossette B; Abraham W; Kataria S; Bastidas R; Bhiman J; Linde C; Bloom NI; Groschel B; Georgeson E; Phelps N; Thomas A; Bals J; Carnathan DG; Lingwood D; Burton DR; Alter G; Padera TP; Belcher AM; Schief WR; Silvestri G; Ruprecht RM; Crotty S; Irvine DJ
    Sci Immunol; 2021 Dec; 6(66):eabf1152. PubMed ID: 34860581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the dilution behaviour of immuno-stimulating complexes (ISCOMs).
    Lendemans DG; Egert AM; Myschik J; Hook S; Rades T
    Pharmazie; 2006 Aug; 61(8):689-95. PubMed ID: 16964712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines.
    Sjölander A; Cox JC
    Adv Drug Deliv Rev; 1998 Dec; 34(2-3):321-338. PubMed ID: 10837684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants.
    Rivera-Patron M; Cibulski SP; Miraballes I; Silveira F
    Methods Mol Biol; 2022; 2469():183-191. PubMed ID: 35508839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and potential application of ISCOMs in veterinary medicine.
    Morein B; Hu KF; Abusugra I
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
    Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
    Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes.
    Copland MJ; Rades T; Davies NM
    Int J Pharm; 2000 Mar; 196(2):135-9. PubMed ID: 10699704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by lipid-film hydration and dialysis.
    Demana PH; Davies NM; Berger B; Vosgerau U; Rades T
    J Pharm Pharmacol; 2004 May; 56(5):573-80. PubMed ID: 15142333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ISCOM-based vaccines: the second decade.
    Sanders MT; Brown LE; Deliyannis G; Pearse MJ
    Immunol Cell Biol; 2005 Apr; 83(2):119-28. PubMed ID: 15748208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISCOM-Matrices Nanoformulation Using the Raw Aqueous Extract of
    Cibulski S; de Souza TA; Raimundo JP; Nascimento YM; Abreu LS; Suarez N; Miraballes I; Roehe PM; de Araújo DAM; Tavares JF; da Silva MS; Silveira F
    Bionanoscience; 2022; 12(4):1166-1171. PubMed ID: 35967762
    [No Abstract]   [Full Text] [Related]  

  • 12. ISCOMs (immunostimulating complexes): the first decade.
    Barr IG; Mitchell GF
    Immunol Cell Biol; 1996 Feb; 74(1):8-25. PubMed ID: 8934649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method.
    Demana PH; Davies NM; Vosgerau U; Rades T
    Int J Pharm; 2004 Feb; 270(1-2):229-39. PubMed ID: 14726138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Quil A on liposomal membranes.
    Paepenmüller T; Müller-Goymann CC
    Int J Pharm; 2014 Nov; 475(1-2):138-46. PubMed ID: 25107288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saponin-adjuvanted particulate vaccines for clinical use.
    Skene CD; Sutton P
    Methods; 2006 Sep; 40(1):53-9. PubMed ID: 16997713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for preparing immune stimulating complexes (ISCOMs) by hydration of freeze-dried lipid matrix.
    Liang M; Toth I; Davies NM
    Eur J Pharm Biopharm; 2008 Mar; 68(3):840-5. PubMed ID: 18182279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
    Rönnberg B; Fekadu M; Morein B
    Vaccine; 1995 Oct; 13(14):1375-82. PubMed ID: 8585296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QS21-Initiated Fusion of Liposomal Small Unilamellar Vesicles to Form ALFQ Results in Concentration of Most of the Monophosphoryl Lipid A, QS21, and Cholesterol in Giant Unilamellar Vesicles.
    Abucayon EG; Rao M; Matyas GR; Alving CR
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
    Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM
    Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.